Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program.
Farooq V, Vranckx P, Mauri L, Cutlip DE, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Negoita M, van Leeuwen F, Neumann FJ, Yeung AC, Garcia-Garcia HM, Serruys PW. Farooq V, et al. Among authors: van leeuwen f. Heart. 2013 May;99(9):626-33. doi: 10.1136/heartjnl-2012-303368. Epub 2013 Mar 6. Heart. 2013. PMID: 23468513 Clinical Trial.
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents.
Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S. Serruys PW, et al. Among authors: van leeuwen f, van geuns rj, van boven aj. N Engl J Med. 2010 Jul 8;363(2):136-46. doi: 10.1056/NEJMoa1004130. Epub 2010 Jun 16. N Engl J Med. 2010. PMID: 20554978 Free article. Clinical Trial.
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.
Camenzind E, Wijns W, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Boersma E, Vranckx P, McFadden E, Serruys PW, O'Neil WW, Jorissen B, Van Leeuwen F, Steg PG; PROTECT Steering Committee and Investigators. Camenzind E, et al. Among authors: van leeuwen f. Lancet. 2012 Oct 20;380(9851):1396-405. doi: 10.1016/S0140-6736(12)61336-1. Epub 2012 Aug 27. Lancet. 2012. PMID: 22951082 Clinical Trial.
Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial.
Diletti R, Garcia-Garcia HM, Bourantas CV, van Geuns RJ, Van Mieghem NM, Vranckx P, Zhang YJ, Farooq V, Iqbal J, Wykrzykowska JJ, de Vries T, Swart M, Teunissen Y, Negoita M, van Leeuwen F, Silber S, Windecker S, Serruys PW; RESOLUTE All Comers Investigators. Diletti R, et al. Among authors: van leeuwen f, van geuns rj, van mieghem nm. Heart. 2013 Sep;99(17):1267-74. doi: 10.1136/heartjnl-2013-303778. Epub 2013 Jun 25. Heart. 2013. PMID: 23800571 Clinical Trial.
Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial.
Wijns W, Steg PG, Mauri L, Kurowski V, Parikh K, Gao R, Bode C, Greenwood JP, Lipsic E, Alamgir F, Rademaker-Havinga T, Boersma E, Radke P, van Leeuwen F, Camenzind E; PROTECT Steering Committee and Investigators. Wijns W, et al. Among authors: van leeuwen f. Eur Heart J. 2014 Oct 21;35(40):2812-20. doi: 10.1093/eurheartj/ehu318. Epub 2014 Aug 8. Eur Heart J. 2014. PMID: 25106761 Clinical Trial.
Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program.
Diletti R, Garcia-Garcia HM, Bourantas C, Van Mieghem NM, van Geuns RJ, Muramatsu T, Zhang YJ, Mauri L, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Neumann FJ, Yeung AC, Saito S, Liu M, van Leeuwen F, Serruys PW. Diletti R, et al. Among authors: van leeuwen f, van geuns rj, van mieghem nm. Catheter Cardiovasc Interv. 2015 May;85(6):952-8. doi: 10.1002/ccd.25828. Epub 2015 Feb 17. Catheter Cardiovasc Interv. 2015. PMID: 25689692
Clinical Outcomes of Percutaneous Coronary Intervention for Bifurcation Lesions According to Medina Classification.
Mohamed MO, Lamellas P, Roguin A, Oemrawsingh RM, Ijsselmuiden AJJ, Routledge H, van Leeuwen F, Debrus R, Roffi M, Mamas MA; e‐Ultimaster investigators. Mohamed MO, et al. Among authors: van leeuwen f. J Am Heart Assoc. 2022 Sep 6;11(17):e025459. doi: 10.1161/JAHA.122.025459. Epub 2022 Aug 24. J Am Heart Assoc. 2022. PMID: 36000428 Free PMC article.
Predicting target lesion failure following percutaneous coronary intervention through machine learning risk assessment models.
Mamas MA, Roffi M, Fröbert O, Chieffo A, Beneduce A, Matetic A, Tonino PAL, Paunovic D, Jacobs L, Debrus R, El Aissaoui J, van Leeuwen F, Kontopantelis E. Mamas MA, et al. Among authors: van leeuwen f. Eur Heart J Digit Health. 2023 Aug 31;4(6):433-443. doi: 10.1093/ehjdh/ztad051. eCollection 2023 Dec. Eur Heart J Digit Health. 2023. PMID: 38045434 Free PMC article.
Prediction of breast cancer risk for adolescents and young adults with Hodgkin lymphoma.
Roberti S, van Leeuwen FE, Diallo I, de Vathaire F, Schaapveld M, Leisenring WM, Howell RM, Armstrong GT, Moskowitz CS, Smith SA, Aleman BMP, Krul IM, Russell NS, Pfeiffer RM, Hauptmann M. Roberti S, et al. Among authors: van leeuwen fe. J Natl Cancer Inst. 2024 Nov 1:djae274. doi: 10.1093/jnci/djae274. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 39485483
1,196 results